Expert Opinion on Biological Therapy, Volume 19, Issue 10 (2019)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Opinion on Biological Therapy, Volume 19, Issue 10 (2019)

See all volumes and issues
Vol 24, 2024 Vol 23, 2023 Vol 22, 2022 Vol 21, 2021 Vol 20, 2020 Volume 19, 2019 Vol 18, 2018 Vol 17, 2017 Vol 16, 2016 Vol 15, 2015 Vol 14, 2014 Vol 13, 2013 Vol 12, 2012 Vol 11, 2011 Vol 10, 2010 Vol 9, 2009 Vol 8, 2008 Vol 7, 2007 Vol 6, 2006 Vol 5, 2005 Vol 4, 2004 Vol 3, 2003 Vol 2, 2002 Vol 1, 2001
Download citations Download PDFs Download issue

Biosimilars

Editorial

Editorial
The role of healthcare providers in accompanying biosimilars in inflammatory bowel diseases
Carla Felice, Daniela Pugliese & Alessandro Armuzzi
Pages: 967-969
Published online: 11 Jan 2019
First Page PreviewforThe role of healthcare providers in accompanying biosimilars in inflammatory bowel diseases | Full Text | References | PDF (418.5 KB) | EPUB
  • 1147 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Drug Evaluation

Article
CT-P13: a review on a biosimilar to infliximab in the treatment of inflammatory bowel disease
Ahmad Albshesh & Shomron Ben-Horin
Pages: 971-978
Published online: 23 Aug 2019
AbstractforCT-P13: a review on a biosimilar to infliximab in the treatment of inflammatory bowel disease | Full Text | References | PDF (755 KB) | EPUB
  • 405 Views
  • 6 CrossRef citations
  • 0Altmetric
Article
Rituximab biosimilar CT-P10 for the treatment of rheumatoid arthritis
Ju-Yang Jung, Ji-Won Kim, Hyoun-Ah Kim & Chang-Hee Suh
Pages: 979-986
Published online: 18 Sep 2019
AbstractforRituximab biosimilar CT-P10 for the treatment of rheumatoid arthritis | Full Text | References | PDF (1.1 MB) | EPUB
  • 293 Views
  • 5 CrossRef citations
  • 0Altmetric
Article
Clinical development of CT-P6 in HER2 positive breast cancer
Chen Fu, Justin Stebbing & Francisco J. Esteva
Pages: 987-992
Published online: 11 Sep 2019
AbstractforClinical development of CT-P6 in HER2 positive breast cancer | Full Text | References | PDF (605.2 KB) | EPUB
  • 327 Views
  • 3 CrossRef citations
  • 0Altmetric

Review

Review
Biosimilars for the treatment of psoriasis
Lluís Puig & Anna López-Ferrer
Pages: 993-1000
Published online: 01 Jul 2019
AbstractforBiosimilars for the treatment of psoriasis | Full Text | References | PDF (740.6 KB) | EPUB
  • 656 Views
  • 28 CrossRef citations
  • 0Altmetric
Review
Switching to biosimilars: current perspectives in immune-mediated inflammatory diseases
Christopher J. Edwards, Jana Hercogová, Helene Albrand & Aurelian Amiot
Pages: 1001-1014
Published online: 06 May 2019
AbstractforSwitching to biosimilars: current perspectives in immune-mediated inflammatory diseases | Full Text | References | PDF (1.2 MB) | EPUB | Supplemental
  • 10548 Views
  • 17 CrossRef citations
  • 0Altmetric
Open Access
Review
Biosimilars for breast cancer
Bruna Migliavacca Zucchetti, Eleonora Nicolò & Giuseppe Curigliano
Pages: 1015-1021
Published online: 10 Jul 2019
AbstractforBiosimilars for breast cancer | Full Text | References | PDF (581.1 KB) | EPUB
  • 333 Views
  • 3 CrossRef citations
  • 0Altmetric
Review
Biosimilars of adalimumab: the upcoming challenge in IBD
Gionata Fiorino, Daniela Gilardi, Carmen Correale, Federica Furfaro, Giulia Roda, Laura Loy, Marjorie Argollo, Mariangela Allocca, Laurent Peyrin-Biroulet & Silvio Danese
Pages: 1023-1030
Published online: 08 Jan 2019
AbstractforBiosimilars of adalimumab: the upcoming challenge in IBD | Full Text | References | PDF (853.8 KB) | EPUB
  • 794 Views
  • 18 CrossRef citations
  • 0Altmetric
Review
Bioequivalence studies with anti-TNF biosimilars
Mercedes Gimeno-Gracia, Carla J. Gargallo-Puyuelo & Fernando Gomollón
Pages: 1031-1043
Published online: 31 Dec 2018
AbstractforBioequivalence studies with anti-TNF biosimilars | Full Text | References | PDF (1.1 MB) | EPUB
  • 337 Views
  • 5 CrossRef citations
  • 0Altmetric
Review
Rituximab biosimilars for lymphoma in Europe
Wojciech Jurczak, Monika Długosz Danecka & Christian Buske
Pages: 1045-1056
Published online: 30 Sep 2019
AbstractforRituximab biosimilars for lymphoma in Europe | Full Text | References | PDF (1.1 MB) | EPUB
  • 7603 Views
  • 11 CrossRef citations
  • 0Altmetric
Open Access

Original Research

Article
Differences in immunogenicity associated with non-product related variability: insights from two pharmacokinetic studies using GP2017, an adalimumab biosimilar
Oliver von Richter, Lena Lemke, Halimuniyazi Haliduola, Alison Balfour, Britta Zehnpfennig, Andrej Skerjanec & Julia Jauch-Lembach
Pages: 1057-1064
Published online: 19 Apr 2019
AbstractforDifferences in immunogenicity associated with non-product related variability: insights from two pharmacokinetic studies using GP2017, an adalimumab biosimilar | Full Text | References | PDF (764 KB) | EPUB | Supplemental
  • 758 Views
  • 5 CrossRef citations
  • 0Altmetric
Article
Population pharmacokinetics of PF-06438179/GP1111 (an infliximab biosimilar) and reference infliximab in patients with moderately to severely active rheumatoid arthritis
Rameshraja Palaparthy, Muhammad I. Rehman, Oliver von Richter & Donghua Yin
Pages: 1065-1074
Published online: 08 Jul 2019
AbstractforPopulation pharmacokinetics of PF-06438179/GP1111 (an infliximab biosimilar) and reference infliximab in patients with moderately to severely active rheumatoid arthritis | Full Text | References | PDF (1.2 MB) | EPUB | Supplemental
  • 3019 Views
  • 5 CrossRef citations
  • 0Altmetric
Open Access
Article
GP2017, an adalimumab biosimilar: pharmacokinetic similarity to its reference medicine and pharmacokinetics comparison of different administration methods
Oliver von Richter, Lena Lemke, Halimuniyazi Haliduola, Rainard Fuhr, Thomas Koernicke, Ellen Schuck, Maria Velinova, Andrej Skerjanec, Johann Poetzl & Julia Jauch-Lembach
Pages: 1075-1083
Published online: 30 Jan 2019
AbstractforGP2017, an adalimumab biosimilar: pharmacokinetic similarity to its reference medicine and pharmacokinetics comparison of different administration methods | Full Text | References | PDF (884.8 KB) | EPUB | Supplemental
  • 1409 Views
  • 25 CrossRef citations
  • 0Altmetric
Article
Mechanism of action of the trastuzumab biosimilar CT-P6
Sun Ah Jeong, Jung Min Choi, Jun Mo Park, Jun Young Lee, So Jung Lee, Su Yeon Lee, Si Yeon Lee, Yoon A Park, Hee Jeong Jeong, Yoo Cheol Song, Sung Hwan Kim & Shin Jae Chang
Pages: 1085-1095
Published online: 13 Dec 2018
AbstractforMechanism of action of the trastuzumab biosimilar CT-P6 | Full Text | References | PDF (1.1 MB) | EPUB | Supplemental
  • 494 Views
  • 8 CrossRef citations
  • 0Altmetric
Article
Long-term safety, efficacy, and immunogenicity of adalimumab biosimilar BI 695501 and adalimumab reference product in patients with moderately-to-severely active rheumatoid arthritis: results from a phase 3b extension study (VOLTAIRE-RAext)
Stanley B. Cohen, Niklas Czeloth, Eric Lee, Piotr A. Klimiuk, Nuala Peter & Girish Jayadeva
Pages: 1097-1105
Published online: 06 Aug 2019
AbstractforLong-term safety, efficacy, and immunogenicity of adalimumab biosimilar BI 695501 and adalimumab reference product in patients with moderately-to-severely active rheumatoid arthritis: results from a phase 3b extension study (VOLTAIRE-RAext) | Full Text | References | PDF (1.3 MB) | EPUB | Supplemental
  • 2903 Views
  • 17 CrossRef citations
  • 0Altmetric
Open Access

Explore articles

Explore the most recently published articles

Management of proctitis in ulcerative colitis and the place of biological therapies
Diletta De Deo et al.
Review Article | Published online: 17 Jun 2024
Open Access
An evaluation of nadofaragene firadenovec-vncg for the treatment of high-risk BCG-unresponsive non-muscle-invasive bladder cancer
Zine-Eddine Khene et al.
Review Article | Published online: 13 Jun 2024
Progress in second-line antibody therapies for advanced esophageal squamous cell carcinoma
Nozomu Ogura et al.
Review Article | Published online: 11 Jun 2024
Overview of biosimilar medicines in Spain: market dynamics, policies, evidence-based insights and avenues for a sustainable market
Isabel Río-Álvarez et al.
Review Article | Published online: 6 Jun 2024
View all latest articles